Amendment Statement of Principles concerning immune thrombocytopaenia (Balance of Probabilities) (No. 58 of 2022)

Administered by Department of Veterans' Affairs

Legislation au F2022L00657 Not in force Legislative Instrument

Legislation content

EXPLANATORY STATEMENT

 

AMENDMENT Statement of Principles concerning

IMMUNE THROMBOCYTOPAENIA

(BALANCE OF PROBABILITIES) (NO. 58 OF 2022)

 

VETERANS' ENTITLEMENTS ACT 1986

MILITARY REHABILITATION AND COMPENSATION ACT 2004

 

  1. This is the Explanatory Statement to the Amendment Statement of Principles concerning immune thrombocytopaenia (Balance of Probabilities) (No. 58 of 2022).

Background

2.             The Repatriation Medical Authority (the Authority) has determined, under subsections 196B(3) and (8) of the Veterans' Entitlements Act 1986 (the VEA), Amendment Statement of Principles concerning immune thrombocytopaenia (Balance of Probabilities) (No. 58 of 2022).

3.             This Instrument amends Statement of Principles concerning immune thrombocytopaenia (Balance of Probabilities) (No. 64 of 2017) (Federal Register of Legislation No. F2017L01449) by:

  • inserting a new paragraph (aa) into the definition of 'specified list of vaccines' in the Schedule 1  Dictionary;
  • inserting a new paragraph (ma) into the definition of 'specified list of viral infections' in the Schedule 1  Dictionary; and
  • inserting a note to the definition of 'specified list of viral infections in the Schedule 1  Dictionary.

 

Day of Commencement

4.             This Instrument also specifies a day of commencement for the amendment in accordance with subsection 12(3) of the Legislation Act 2003.

Consultation

5.             Prior to determining this Instrument, the Authority advertised its intention to undertake an investigation in relation to SARS-CoV-2 infection and coronavirus disease 2019 (COVID-19) vaccines as factors in immune thrombocytopaenia in the Government Notices Gazette of 5 January 2022, and circulated a copy of the notice of intention to investigate to a wide range of organisations representing veterans, service personnel and their dependants.  The Authority invited submissions from the Repatriation Commission, the Military Rehabilitation and Compensation Commission, organisations and persons referred to in section 196E of the VEA, and any person having expertise in the field.  No submissions were received for consideration by the Authority in relation to the investigation.

 

Human Rights

6.             This instrument is compatible with the Human Rights and Freedoms recognised or declared in the International Instruments listed in Section 3 of the Human Rights (Parliamentary Scrutiny) Act 2011.  A Statement of Compatibility with Human Rights follows.

Finalisation of Investigation

7.             The determining of this Instrument finalises the investigation in relation to SARS- CoV- 2 infection and coronavirus disease 2019 (COVID-19) vaccines as factors in immune thrombocytopaenia as advertised in the Government Notices Gazette of 5 January 2022.

References

8.             A list of references relating to the above condition is available on the Authority's website at: www.rma.gov.au. Any other document referred to in this Statement of Principles is available on request to the Repatriation Medical Authority at the following address:

              

Email:    info@rma.gov.au

Post:      The Registrar

Repatriation Medical Authority

GPO Box 1014

BRISBANE    QLD    4001

 


Statement of Compatibility with Human Rights

(Prepared in accordance with Part 3 of the Human Rights (Parliamentary Scrutiny) Act 2011)

 

Instrument No.:   Amendment Statement of Principles No. 58 of 2022

Kind of Injury, Disease or Death: Immune thrombocytopaenia

 

This Legislative Instrument is compatible with the human rights and freedoms recognised or declared in the international instruments listed in section 3 of the Human Rights (Parliamentary Scrutiny) Act 2011.

Overview of the Legislative Instrument

1. This Legislative Instrument is determined pursuant to subsection 196B(3) of the Veterans' Entitlements Act 1986 (the VEA) for the purposes of the VEA and the Military Rehabilitation and Compensation Act 2004 (the MRCA).  Part XIA of the VEA requires the determination of these instruments outlining the factors connecting particular kinds of injury, disease or death with service such being determined solely on the available sound medical-scientific evidence.

2. This Legislative Instrument:-

  • facilitates claimants in making, and the Repatriation Commission and the Military Rehabilitation and Compensation Commission in assessing, claims under the VEA and the MRCA respectively, by specifying the circumstances in which medical treatment and compensation can be extended to eligible persons who have immune thrombocytopaenia;
  • facilitates the review of such decisions by the Veterans' Review Board and the Administrative Appeals Tribunal;
  • includes SARS-CoV-2 infection and coronavirus disease 2019 (COVID-19) vaccines as new factors which the current sound medical-scientific evidence indicates must exist before it can be said that, on the balance of probabilities, immune thrombocytopaenia is connected with the circumstances of eligible service rendered by a person; and
  • amends Instrument No. 64 of 2017 to ensure it better reflects the available sound medical-scientific evidence concerning immune thrombocytopaenia. 

3. The Instrument is assessed as being a technical instrument which improves the medico-scientific quality of outcomes under the VEA and the MRCA. 

Human Rights Implications

4. This Legislative Instrument does not derogate from any human rights. It promotes the human rights of veterans, current and former Defence Force members as well as other persons such as their dependents, including:

  • the right to social security (Art 9, International Covenant on Economic, Social and Cultural Rights; Art 26, Convention on the Rights of the Child and Art 28, Convention on the Rights of Persons with Disabilities) by helping to ensure that the qualifying conditions for the benefit are 'reasonable, proportionate and transparent'[1];
  • the right to an adequate standard of living (Art 11, ICESCR; Art 27, CRC and Art 28, CRPD) by facilitating the assessment and determination of social security benefits;
  • the right to the enjoyment of the highest attainable standard of physical and mental health (Art 12, ICESCR and Art 25, CRPD), by facilitating the assessment and determination of compensation and benefits in relation to the treatment and rehabilitation of veterans and Defence Force members;
  • the rights of persons with disabilities by facilitating the determination of claims relating to treatment and rehabilitation (Art 26, CRPD); and
  • ensuring that those rights "will be exercised without discrimination of any kind as to race, colour, sex, language, religion, political or other opinion, national or social origin, property, birth or other status" (Art 2, ICESCR).

Conclusion

This Legislative Instrument is compatible with human rights as it does not derogate from and promotes a number of human rights.

 

Repatriation Medical Authority

 

 

 

 

 

 

[1] In General Comment No. 19 (The right to social security), the Committee on Economic, Social and Cultural Rights said (at paragraph 24) this to be one of the elements of ensuring accessibility to social security.

Overview

The Amendment Statement of Principles concerning immune thrombocytopaenia (Balance of Probabilities) (No. 58 of 2022), introduced by the Repatriation Medical Authority under the Veterans' Entitlements Act 1986 and the Military Rehabilitation and Compensation Act 2004, addresses the evolving medical understanding of immune thrombocytopaenia, particularly in relation to SARS-CoV-2 infection and COVID-19 vaccines. This amendment aims to ensure that the assessment and compensation processes under these Acts are aligned with the latest medical-scientific evidence, facilitating more accurate and fair determinations for veterans and service personnel. The instrument amends the existing Statement of Principles concerning immune thrombocytopaenia, incorporating new factors and definitions to reflect the current state of medical knowledge, thereby supporting the policy objective of providing timely and appropriate benefits to those affected by immune thrombocytopaenia. This amendment not only improves the medico-scientific quality of outcomes under the Acts but also upholds various human rights, including the right to social security and the right to health, by ensuring the qualifying conditions for benefits are reasonable, proportionate, and transparent.

Scope and Application

The Amendment Statement of Principles concerning immune thrombocytopaenia (Balance of Probabilities) (No. 58 of 2022) applies to veterans and other eligible persons under the Veterans' Entitlements Act 1986 and the Military Rehabilitation and Compensation Act 2004. It specifically addresses the connection between immune thrombocytopaenia and SARS-CoV-2 infection and COVID-19 vaccines, updating the existing Statement of Principles concerning immune thrombocytopaenia (Balance of Probabilities) (No. 64 of 2017) to reflect the latest medical-scientific evidence. This amendment facilitates the process of making and assessing claims for medical treatment and compensation related to immune thrombocytopaenia, ensuring that the criteria for eligibility are based on the most current and reliable evidence. The amendment is compatible with human rights and does not derogate from any rights, promoting the rights of veterans, current and former Defence Force members, and their dependents. The instrument's technical nature aims to improve the quality of medico-scientific outcomes under the relevant Acts.

Key Provisions

The main operative sections of the Amendment Statement of Principles concern immune thrombocytopaenia (Balance of Probabilities) (No. 58 of 2022) involve the insertion of new paragraphs (aa) and (ma) into the definitions of 'specified list of vaccines' and'specified list of viral infections', respectively, in the Schedule 1 – Dictionary of the Veterans' Entitlements Act 1986 (VEA) (sections 196B(3) and (8)). This amendment is made to better reflect the available sound medical-scientific evidence regarding immune thrombocytopaenia, specifically incorporating SARS-CoV-2 infection and coronavirus disease 2019 (COVID-19) vaccines as factors that must exist before it can be said that, on the balance of probabilities, immune thrombocytopaenia is connected with the circumstances of eligible service rendered by a person. The Act imposes obligations and requirements on the Repatriation Medical Authority (the Authority) to determine such statements of principles based on sound medical-scientific evidence, ensuring that the criteria for claims under the VEA and the Military Rehabilitation and Compensation Act 2004 (MRCA) are 'reasonable, proportionate, and transparent'. This process involves facilitating claimants in making claims and the Repatriation Commission and the Military Rehabilitation and Compensation Commission in assessing those claims. Additionally, the Authority must consult with relevant stakeholders, such as the Repatriation Commission, the Military Rehabilitation and Compensation Commission, and organisations representing veterans and service personnel, although it is noted that no submissions were received in this instance. Any breaches of the requirements under the VEA and MRCA, including the failure to provide accurate or timely statements of principles, could lead to civil or administrative consequences, such as the invalidity of claims or decisions that are later found to be based on incorrect or outdated evidence. While specific offences, penalties, or criminal consequences are not detailed in the provided text, the legislative framework allows for such measures to be in place to ensure the integrity and fairness of the claims process. The maximum penalties for such breaches would depend on the specific nature of the breach and applicable laws at the time.

Legal classification tags

Area of Law
Veterans' Law
Instrument
Regulation
Concepts
Definitions & Interpretation
Licensing & Registration
Consultation Requirements
Prohibited Conduct
Catchwords
immune thrombocytopaenia

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.